Modulation of CCR2 in rheumatoid arthritis: A double-blind, randomized, placebo-controlled clinical trial
✍ Scribed by Clarissa E. Vergunst; Daniëlle M. Gerlag; Luba Lopatinskaya; L. Klareskog; M. D. Smith; F. van den Bosch; Huib J. Dinant; Yih Lee; Timothy Wyant; Eric W. Jacobson; Dominique Baeten; Paul P. Tak
- Publisher
- John Wiley and Sons
- Year
- 2008
- Tongue
- English
- Weight
- 150 KB
- Volume
- 58
- Category
- Article
- ISSN
- 0004-3591
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract ## Objective To determine whether patients with undifferentiated arthritis (UA; inflammatory, nontraumatic arthritis that cannot be diagnosed using current classification criteria) benefit from treatment with methotrexate (MTX). ## Methods The PRObable rheumatoid arthritis: Methotrex
## Abstract ## Objective To assess the safety and potential efficacy of etanercept in the treatment of Sjögren's syndrome (SS). ## Methods This pilot study was a 12‐week randomized, double‐blind, placebo‐controlled trial of etanercept, with 14 subjects in each group. Patients received 25 mg of e